Covid-19 vaccine could be ready by October end
Pfizer, a leading global pharmaceutical company, believes that a vaccine to prevent Covid-19 could be ready by the end of October.
New York: Pfizer, a leading global pharmaceutical company, believes that a vaccine to prevent Covid-19 could be ready by the end of October. This information was given by the CEO of the company Albert Bourla.
Pfizer, in collaboration with German mRNA company BioNTech, is conducting clinical trials in the United States and Europe for the BNT162 vaccine ceremony to prevent covid-19.
"If things go well, we will have solid evidence of safety and effectiveness for the FDA (US Food and Drug Administration) and EMA (European Medicines Agency), by the end of October," Bourla said at the event.
Speakers at the event included AstraZeneca CEO Pascal Soriot, GlaxoSmithKline CEO Emma Walmsley, Johnson & Johnson's Chief Scientific Officer Paul Stoffles. Each of these companies is developing vaccines for the prevention of the disease in collaboration with its partners.
According to the WHO, it is important to evaluate vaccines as much as possible because it is not possible to estimate how useful they will be.